UNSPSC 51102830: Cetylpyridinium/chloroxylenol/triacetin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE109. This VA Drug Class (DE109) classifies this compound as belonging to the group ANTI-INFECTIVE, TOPICAL, OTHER.

UNSPSC 51102830 Cetylpyridinium/chloroxylenol/triacetin is a Commodity code that in practice does not see substantive recent state and local procurement activity aligned with its nominal scope. The two opportunities posted under this code in the past three months are unrelated to the antimicrobial active ingredient the code describes: the Illinois Department of Public Health's pharmaceutical warehouse piggyback award through MMCAP Infuse covers antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) unrelated to the code's chemical family, and Seminole County, Florida's IFB for Naloxone and drug deactivation systems is a public health emergency-response procurement entirely outside the code's scope. The mismatch suggests either miscoding at the issuing bodies or that this code does not align with current state and local buying patterns for antiseptic or antimicrobial formulations.

Activity under this code appears dormant for procurement professionals tracking active opportunities. The Illinois award (completed August 28, 2026) and the Seminole County IFB (posted June 30, 2026, with July 26, 2023 response deadline — an apparent date error in the source) are the only recent postings, and neither represents genuine demand for cetylpyridinium/chloroxylenol/triacetin formulations. No trend across multiple issuing bodies, geographic spread, or recurring procurement categories emerges from the data. State and local buyers interested in this specific active-ingredient class should monitor directly with state health departments, correctional facilities, and water-treatment authorities rather than rely on this code for market signals.